TET1 was first identified as a fusion partner of the mixed lineage leukemia (MLL) gene in acute myeloid leukemia, and it is now clear that TET1 plays an essential oncogenic role in MLL-rearranged leukemia [27, 28, 34]. The gene discussed is TET1; the disease is acute myeloid leukemia.